Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1228559-81-6, Linaprazan glurate [inn], 3vg4d399dt, 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) pentanedioate, Pentanedioic acid, 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) ester, Unii-3vg4d399dt

Molecular Formula

C₂₆H₃₂N₄O₅

Molecular Weight

480.6 g/mol

InChI Key

GPHPBXRKAJSSIC-UHFFFAOYSA-N

FDA UNII

3VG4D399DT

LINAPRAZAN GLURATE is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication.

1 2D Structure

Linaprazan Glurate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[2-[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carbonyl]amino]ethoxy]-5-oxopentanoic acid

2.1.2 InChI

InChI=1S/C26H32N4O5/c1-16-7-5-8-17(2)21(16)14-28-22-13-20(15-30-19(4)18(3)29-25(22)30)26(34)27-11-12-35-24(33)10-6-9-23(31)32/h5,7-8,13,15,28H,6,9-12,14H2,1-4H3,(H,27,34)(H,31,32)

2.1.3 InChI Key

GPHPBXRKAJSSIC-UHFFFAOYSA-N

2.2 Other Identifiers

2.2.1 UNII

3VG4D399DT

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 1228559-81-6

2. Linaprazan Glurate [inn]

3. 3vg4d399dt

4. 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) Pentanedioate

5. Pentanedioic Acid, 1-(2-(((8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)carbonyl)amino)ethyl) Ester

6. Unii-3vg4d399dt

7. 5-(2-(8-((2,6-dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic Acid

8. Glurate De Linaprazan

9. Glurato De Linaprazan

10. Schembl2367993

11. Chembl5095187

12. Glxc-26945

13. Ex-a8505

14. Akos040756559

15. 5-[2-[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carbonyl]amino]ethoxy]-5-oxopentanoic Acid

16. Da-64980

17. Ms-28939

18. Hy-145578

19. Cs-0376365

20. G79583

21. 5-{2-[(8-{[(2,6-dimethylphenyl)methyl]amino}-2,3-dimethylimidazo[1,2-a]pyridin-6-yl)formamido]ethoxy}-5-oxopentanoic Acid

2.3.2 Other Synonyms

1. Linaprazan

2. Azd-0865

3. 248919-64-4

4. Azd0865

2.4 Create Date

2010-07-06

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₃₂N₄O₅
Molecular Weight	480.6 g/mol
XLogP3	3.7
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	12
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	122
Heavy Atom Count	35
Formal Charge	0
Complexity	725
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1